BRENNEN

Industries / Health / Pharmaceuticals / Contract drug manufacturing

Fill and finish

Fill-and-finish plants put a finished medicine into sterile vials, syringes or cartridges, freeze-dry it where needed, then seal, inspect and pack it, and many drug companies hire contract makers to do it.

6

Milestones achieved, from 2004 to 2024.

1

To watch for: announced, not yet confirmed outside.

2

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 2004

    Rules for germ-free filling

    Aseptic processing means filling a medicine that cannot be sterilised by heat in its final container, so the product, containers and air must be kept free of germs at every step. In September 2004 the US Food and Drug Administration (FDA) replaced its 1987 guideline on the subject. The new guidance covers staff training, cleanroom design, process design, quality control, monitoring of the rooms and review of production records. An appendix covers isolators, sealed enclosures that keep people's hands and breath away from open containers.

    fda.gov

    Credit

    FDA

  2. 2011

    One filler stops, shortages follow

    Ben Venue Laboratories, a Boehringer Ingelheim unit in Bedford, Ohio, made sterile injectable medicines under contract. It was the only maker of Doxil, a cancer drug it made for Johnson & Johnson's Janssen. In 2011 it suspended manufacturing because of manufacturing and quality problems, and Doxil ran critically short. In February 2012 the FDA allowed a substitute, Lipodox, to be imported from a Sun Pharma plant in India. Ben Venue resumed limited production in October 2012 and entered a consent decree, a court-enforced agreement, with the FDA. It said it had spent more than USD 300 million on fixes, but it ended production at the end of 2013 and let go most of its 1,100 staff.

    Lessonwhen one contract filler is the only source of a medicine, a quality failure at that plant becomes a national shortage.

    raps.orgbiopharminternational.comfiercepharma.com

    Credit

    Ben Venue Laboratories; Boehringer Ingelheim; FDA

  3. 2018

    Filling without glove ports

    Most isolators have glove ports, sleeves through which operators reach in. Vanrx Pharmasystems of Vancouver sold the SA25, which it called the first gloveless robotic isolator for aseptic filling: robots inside handle, fill and close vials, syringes or cartridges. The machine is now sold by Cytiva. In 2018 Terrence Hollis of the contract maker Patheon described installing one. Small differences in the size of incoming containers could upset the robot's moves, so suppliers' specifications had to be checked. Some situations still needed an operator, who stepped in by directing the robot.

    LessonRobots remove the reaching-in, not the need for trained people, and the parts they handle must be made to tighter sizes.

    pda.orgprnewswire.comcdn.cytivalifesciences.com

    Credit

    Vanrx Pharmasystems; Patheon

  4. 2020

    Pandemic doses filled under contract

    In June 2020 Moderna hired Catalent to fill and pack vials of its COVID-19 vaccine at Catalent's plant in Bloomington, Indiana, for an initial 100 million doses. In April 2021 Catalent gave Moderna a new high-speed filling line there until June 2023, with inspection, labelling, cartoning and packing.

    pharmtech.com

    Credit

    Catalent; Moderna

  5. 2022

    Europe rewrites sterile rules

    On 22 August 2022 the European Commission adopted a new Annex 1, the EU rules for making sterile medicines, replacing the 2007 version. EU inspectors and the PIC/S, a scheme through which medicine inspectors of many countries share rules, had asked for it jointly. It took effect on 25 August 2023, and a clause on loading and unloading freeze-dryers a year later. It says every plant should have a contamination control strategy, a plan that names the critical control points and checks how well every control against germs and particles works. It says barrier systems or isolators should be considered and any alternative justified, and it names robotic systems among the tools to consider.

    health.ec.europa.eu

    Credit

    European Commission; PIC/S

  6. 2024

    A drug company buys fillers

    Novo Holdings, the investment company that controls Novo Nordisk, completed its purchase of Catalent on 18 December 2024, for an enterprise value of about USD 16.5 billion. As part of the deal Novo Nordisk took three of Catalent's nearly 50 sites, all of them fill-finish plants: Anagni, Italy; Bloomington, Indiana; and Brussels, Belgium.

    novoholdings.dk

    Credit

    Novo Holdings; Catalent; Novo Nordisk

Watch for

  1. Freeze-drying in hours

    Freeze-drying, or lyophilisation, removes water from a filled vial by freezing it and lowering the pressure so that the ice turns straight to vapour. In an ordinary batch freeze-dryer a cycle takes days. Thermo Fisher Scientific and RheaVita say that continuous freeze-drying, which treats vials in a steady stream, runs in Thermo Fisher's development labs in Monza, Italy, and cuts cycle times from days to hours without harming product quality. They present it as a path to GMP manufacturing. Purdue University's LyoHUB roadmap, summarised in October 2026, still lists a GMP-scale unit as not yet shown for spin freeze-drying, one continuous method.

    Achieved whena regulator approves a commercial medicine freeze-dried this way at a contract plant, or an outside group publishes matching timing and quality data.

    patheon.combioprocessonline.com

    Claimed by

    Thermo Fisher Scientific and RheaVita, September 2026

Open

  1. 01

    Robots clear line stoppages

    A copy of a filling line's feed rail, run with empty vials and stoppers, where a robot arm watching through a camera clears common stoppages with no person steering it: it lifts a fallen vial, removes a wrongly fed stopper and re-seats a tipped tray of containers.

    The brief
    Credit · unclaimed
  2. 02

    Shared freeze-drying run data

    An open collection of freeze-drying runs of drug-free solutions, such as sugar dissolved in water, in standard vials. Each run records shelf temperature, chamber pressure, product temperature, vial type, fill volume and when primary drying, the stage that removes the ice, ended. Add a scored test of how well open models predict primary drying time.

    The brief
    Credit · unclaimed

Open 01 · the brief

Robots clear line stoppages

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A copy of a filling line's feed rail, run with empty vials and stoppers, where a robot arm watching through a camera clears common stoppages with no person steering it: it lifts a fallen vial, removes a wrongly fed stopper and re-seats a tipped tray of containers.

Why it is still open

On isolator lines operators still clear such faults by hand through glove ports. In 2024 Ivo Dekker and colleagues at KU Leuven had 22 untrained volunteers remove faulty plungers (syringe stoppers) with a robot they steered remotely, helped by a camera system and automatic motion for large moves. A fix took about 30 seconds with still plungers and 21 seconds with moving ones, against 2 to 3 minutes by glove. A person still guided the fine motion, and only one kind of fault was tried.

link.springer.com

Built with what exists

A 3D-printed or machined copy of a feed rail; empty glass vials and stoppers; an object detector such as YOLOv8, which Dekker's team used; a low-cost open-source arm with LeRobot (the note "No download"); Praxis-1's open weights (the note "Open robot model weights").

  1. First step

    Build the rail and record 50 remotely steered demonstrations of lifting a fallen vial.

  2. Done looks like

    Three fault types, 20 filmed attempts at each with no human control, and a published tally of successes and median time per fix, set against the 2-to-3-minute glove figure.

Open 02 · the brief

Shared freeze-drying run data

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

An open collection of freeze-drying runs of drug-free solutions, such as sugar dissolved in water, in standard vials. Each run records shelf temperature, chamber pressure, product temperature, vial type, fill volume and when primary drying, the stage that removes the ice, ended. Add a scored test of how well open models predict primary drying time.

Why it is still open

LyoHUB's Lyo2040 roadmap, summarised in October 2026, says AI tools for freeze-drying depend on whether high-quality, standardised data sets exist, and calls for shared experimental databases. LyoHUB's own tool for logging run details saves its files to a lab drive. A search of Zenodo, a public data archive, found no collection of many runs. The roadmap also says freeze-dried products made up 13% of the FDA's shortage list in 2021.

bioprocessonline.comgithub.com

Built with what exists

LyoPRONTO, LyoHUB's open-source freeze-drying model (GPL-3.0 licence), and its Julia version; the file format of LyoHUB's cycle_metadata_logger; Python; Zenodo for archiving.

github.com

  1. First step

    Copy every published primary-drying run that gives full temperature and pressure traces into the logger's format, and publish the list with each paper's licence.

  2. Done looks like

    At least 100 runs from at least three freeze-dryer models and two labs, under an open licence, with LyoPRONTO's error in hours for primary drying time reported on runs held back from tuning.